Grandfield & Dodd, LLC Biogen Inc. Transaction History

Grandfield & Dodd, LLC

  • $1.49 Billion
  • Q2 2024

A detailed history of Grandfield & Dodd, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 1,199 shares of BIIB stock, worth $222,630. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,199
Previous 1,199 -0.0%
Holding current value
$222,630
Previous $258,000 7.36%
% of portfolio
0.02%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
SELL
$275.25 - $318.06 $44,040 - $50,889
-160 Reduced 11.77%
1,199 $341,000
Q1 2023

Apr 28, 2023
BUY
$256.56 - $292.34 $348,665 - $397,290
1,359 New
1,359 $377,000
Q4 2021

Feb 08, 2022
SELL
$223.92 - $287.77 $184,286 - $236,834
-823 Closed
0 $0
Q1 2021

Apr 22, 2021
SELL
$242.95 - $284.63 $33,527 - $39,278
-138 Reduced 14.36%
823 $230,000
Q3 2020

Nov 03, 2020
SELL
$264.77 - $305.71 $1,059 - $1,222
-4 Reduced 0.41%
961 $270,000
Q2 2020

Jul 24, 2020
SELL
$258.66 - $342.55 $254,262 - $336,726
-983 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$268.85 - $341.04 $5,914 - $7,502
22 Added 2.29%
983 $311,000
Q2 2019

Jul 29, 2019
SELL
$219.29 - $241.72 $14,473 - $15,953
-66 Reduced 6.43%
961 $225,000
Q2 2018

Jul 27, 2018
SELL
$257.52 - $306.91 $30,902 - $36,829
-120 Reduced 10.46%
1,027 $298,000
Q3 2017

Nov 03, 2017
BUY
$281.15 - $329.69 $322,479 - $378,154
1,147
1,147 $359,000

Others Institutions Holding BIIB

# of Institutions
1,049
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email